Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.08 | -1.62% | 4.86 | 5.21 | 4.82 | 5.17 | 4.94 | 17:59:54 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.82 | 6.60 | 1.78 | 26.97% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 115 | 28,600 | $ 5.09 | $ 145,495 | 13,189 | 4.24 - 9.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:37 | 1 | $ 4.87 | USD |
Entasis Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 64.60M | 13.29M | $ -32.95M | 78.69 | - | 13.27M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | 0.20% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.75 | 5.21 | 4.70 | 4.86 | 6,678 | 0.11 | 2.32% |
| 1 Month | 4.9757 | 5.4361 | 4.24 | 4.94 | 10,780 | -0.1157 | -2.33% |
| 3 Months | 6.05 | 6.22 | 4.24 | 5.07 | 11,310 | -1.19 | -19.67% |
| 6 Months | 6.24 | 9.25 | 4.24 | 6.03 | 14,463 | -1.38 | -22.12% |
| 1 Year | 5.04 | 9.25 | 4.24 | 6.17 | 12,185 | -0.18 | -3.57% |
| 3 Years | 13.45 | 13.70 | 3.9703 | 7.70 | 30,146 | -8.59 | -63.87% |
| 5 Years | 13.45 | 13.70 | 3.9703 | 7.70 | 30,146 | -8.59 | -63.87% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. It has the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes etx2514sul, zoliflodacin, etx0282cpdp, and nbp program. |
